UCalgary scholar receives $1M for bold spinal cord injury research

Calgary, AB – Dr. Aaron Phillips, PhD, an associate professor at the University of Calgary, is the 2023 recipient of the $1-million Hopewell M.I.N.D. Prize to advance his work in spinal cord injury. The research project was selected by an international panel of experts, including representatives from Harvard Medical School, the Weizmann Institute of Science and the Howard Hughes Medical Institute.

The judges evaluated the top three finalists on the potential impact of their proposed research projects. The successful project will test a way to reduce damage and support neuro-recovery after spinal cord injury.

“I am so grateful to the Hotchkiss Brain Institute and (philanthropist) Sanders Lee for supporting our innovative research, which is at a critical point where this injection of funding will turn this bold idea into something that changes lives. The M.I.N.D. Prize is a tremendous boost that will help our lab to conduct transformative research in medicine.”

Dr. Aaron Phillips, associate professor, Cumming School of Medicine

The Hopewell M.I.N.D. (Maximizing Innovation in Neuroscience Discovery) Prize was created in 2021 through a $10-million commitment from Calgary philanthropist Sanders Lee, the founder of the Hopewell Group of Companies. The prize aims to spark innovation through supporting cutting-edge research at the Hotchkiss Brain Institute (HBI) at the Cumming School of Medicine.

“What defines an entrepreneurial mindset, whether in research or in the community is the willingness to take chances and go for a high-impact outcome. The M.I.N.D. Prize brings these high-impact ideas to Calgary and provides opportunities for potential lifesaving discoveries for humankind.”

Sanders Lee, founder, Hopewell Group of Companies

As the recipient of the 2023 prize, Phillips plans to use the award to test new ways to prevent spinal cord reduce damage and support healing.

“All three finalists presented high-calibre projects that are cutting-edge in their fields. The MIND Prize has the power to generate significant new discoveries benefitting people living with neurological disease.”

Dr. David Park, PhD, director, Hotchkiss Brain Institute

The two runners-up for the prize were Dr. Deborah Kurrasch, PhD, with her project to develop a new, better-tolerated psychedelic drug for the treatment of mental illness, and Dr. Wee Yong, PhD, with his project to test new ways to reducing scarring and damage on injured cells within the central nervous system in multiple sclerosis, so they can repair themselves.

“The Hopewell MIND prize is a key example of the school of medicine and the University of Calgary’s commitment to and celebration of innovation. Our focus on innovation supports our researchers and trainees. It guides our researchers in becoming entrepreneurs and strengthens our ties with our community partners – people who invest in risk and give to discovery research.”

Dr. Todd Anderson, MD, dean, Cumming School of Medicine

The Hopewell M.I.N.D prize competition for the 2023-24 year opens on November 1. This year, eligibility has been expanded to include post-doctoral fellows. The 2024 M.I.N.D. Prize competition will accept applications from fellows and HBI members as a team. These teams will propose impactful and innovative projects in their pursuit of the $1 million prize. Visit the web page as of November 1 for all the information.

Aaron Phillips is an associate professor in the departments of Physiology and Pharmacology, Cardiac Sciences and Clinical Neurosciences and director of the Restore Network at the Cumming School of Medicine (CSM). He is a member of the Libin Cardiovascular Institute, and Hotchkiss Brain Institute at the CSM. 

Deborah Kurrasch is a professor in the departments of Medical Genetics and Biochemistry & Molecular Biology at the Cumming School of Medicine (CSM) and a member of the Hotchkiss Brain Institute, Alberta Children’s Hospital Institute, and Owerko Centre at the CSM.

Wee Yong is a professor of in the departments of Clinical Neurosciences and Oncology and co-leads UCalgary’s Multiple Sclerosis NeuroTeam. He is a member of the Hotchkiss Brain Institute  and the Snyder Institute for Chronic Diseases at the CSM.
 

Media inquiries

Kelly Johnston
Communications, Cumming School of Medicine
403-617-8791
kelly.johnston2@ucalgary.ca

About the University of Calgary
UCalgary is Canada’s entrepreneurial university, located in Canada’s most enterprising city. It is a top research university and one of the highest-ranked universities of its age. Founded in 1966, its 35,000 students experience an innovative learning environment, made rich by research, hands-on experiences and entrepreneurial thinking. It is Canada’s leader in the creation of start-ups. Start something today at the University of Calgary.

For more information, visit ucalgary.ca. Stay up to date with UCalgary news headlines on Twitter @UCalgary. For access to UCalgary news releases, images and b-roll, and details on faculties and how to reach experts, check out our newsroom at ucalgary.ca/newsroom.

About the Hotchkiss Brain Institute
The Hotchkiss Brain Institute (HBI) consists of more than 300 scientists and clinician-scientists who are dedicated to advancing brain and mental health research and education. The institute leads the Brain and Mental Health research strategy at the University of Calgary, toward a better understanding of the brain and nervous system and new treatments for neurological and mental health disorders, aimed at improving quality of life and patient care. Learn more about the HBI.